Protembis Announces Completion of ? 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors
Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a ? 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE)...
Source: lelezard.com